A new IPO is coming out on Wednesday. Cramer fronted it. Ticker will be EM. Looks good. They are a huge player in the electronic medical billing and administration industry. They have a great vertical structure which gives them the ability to charge at every step in the medical billing and record keeping process while also saving healthcare providers money.
GME has sustained double digit earnings growth since 2004 with a strong correlation in the stock performance. The recession of 2008 has resulted in a disconnect between GME’s earnings curve and its stock price. This indicates an opportunity to buy into GME while its earnings power remains unrecognized by the market. Chief Financial Officer David Carlson has bought in excess of $1 million worth of GME stock. This is an indication that insiders inside the company are bullish. GME is valued at $35.73 for FY2010. With a current price of $22.86, GME is 56% undervalued for the fiscal year. GME’s PE indicates the company is cheap relative to its competitors. Quarterly revenue growth is above the industry average. Gross and operating margins are also above GME’s leading competitors. [more]
My financial model (which can be downloaded at www.betapeg.com) has indicated to me that DVN is in financial trouble. The stock is grossly overvalued. The company is losing billions. Current liabilities are 27% higher than current assets which indicates a liquidity crisis.
This company is in serious trouble. Whatever management is doing, they'r doing it wrong!
For PDF version, go to... [more]
I have just finished my first quarter stock analysis of my watchlist which includes all the stocks in my active CAPS ratings list. I publish the quality of the stock through a rating, and I also publish if the stock is expensive or cheap. Outperform goes to stocks which have high quality ratings and are also cheap. You can view my results are... [more]